Dermatology CRO Market to Hit $11.04Billion By 2030

SHARE THIS ARTICLE

The global dermatology CRO market size is expected to be worth around US$ 11.04 billion by 2030, according to a new report by Vision Research Reports.

The global dermatology CRO market size was valued at US$ 6.17 billion in 2020 and is anticipated to grow at a CAGR of 8.9% during forecast period 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38688

Dermatology CRO Market (By Type: Drug Discovery, Preclinical, Clinical; By Service: Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and Site Recruitment, Technology) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Report Coverage

Report Scope Details
Market Size USD 11.04 billion by 2030
Growth Rate CAGR of 8.9% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Service
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned IQVIA; ICON Plc; Charles River Laboratory; Pharmaceutical Product Development, LLC

Growth Factors

 The rise in demand for topical dermatological medications, such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients, to treat acne is a major factor driving the market. Furthermore, increased awareness regarding skin diseases, high demand for speedy diagnosis, and an increase in the prevalence of skin cancer and other skin problems are all driving the industry forward.

Factors such as increased investment in R&D programs, a preference for outsourcing tasks due to time and cost constraints, and patent expiration in the dermatology industry are some of the key factors expected to drive the market over the forecast period. Contract research outsourcing collaborations provide cutting-edge services, thus pharmaceutical players and government agencies prefer to delegate projects to dermatology CROs, allowing the market to develop.

By Type Analysis

The clinical segment accounted the dermatology contract research organizations market in 2020 with a revenue share of over 76.0%. The expanding number of biologics, the growing need for personalized medicines and orphan drugs, and the demand for innovative technologies are all contributing to the segment growth.

phase III clinical trials are one of the most expensive stages of a clinical trial, outsourcing them to dermatology CROs helped the clinical segment to gain the largest revenue share in 2020. The preclinical segment is expected to expand at the highest CAGR of 8.5% over the forecast period

By Service Analysis

Clinical monitoring dominated for the largest revenue share of more than 21.0% in 2020 and is expected to maintain its position during the forecast period. This could be due to an increase in the number of clinical trials and the need to monitor those trials, which is driving up demand for services.

dermatology clinical research has been outsourced to CROs for a variety of reasons, including cost-effectiveness and technical knowledge. The use of smart analytics and real-time data capture technologies in the healthcare sector is expected to improve clinical monitoring data.

By Phase Analysis

the phase III segment accounted the market with a revenue share of over 51.0% as phase III clinical studies are the costliest and involve a large number of participants. With 59 novel therapeutic medicines approved by the FDA between 2015 and 2016, the median cost of a single-phase III clinical study is roughly USD 19.0 million.

Phase III also necessitates a larger number of patients and, in many cases, a longer treatment term. The phase II segment held the second-largest revenue share in 2020. This research is split into two parts. The first step involves looking at a variety of doses as well as efficacy trials, and the second half involves deciding on a dose.

By Regional Analysis

Asia Pacific accounted the market with a revenue share of over 41.0% and is expected to grow rapidly in the years to come. This is due to the high prevalence of chronic illnesses, the availability of different populations, the ease with which patients may be recruited and retained, and the implementation of laws that meet acceptance criteria.

Due to the biggest number of trials conducted and outsourced in the area, the market for dermatology CROs in North America captured a significant revenue share in 2020. The growth of this regional market has also been fueled by the increasing government support for R&D activities through grants and money to research institutes and corporations.

Key Players

  • IQVIA HOLDINGS INC.
  • Covance Inc.
  • Pharmaceutical Product Development, LLC (PPD)
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • Icon, Plc
  • Medidata Solutions, Inc.
  • Syneos Health
  • Pharmaron
  • GVK Biosciences Private Limited
  • Wuxi AppTec
  • MEDPACE HOLDINGS, INC.
  • PRA Health Sciences
  • CTI Clinical Trial & Consulting
  • Bioskin
  • Proinnovera
  • Biorasi
  • Javara
  • TFS

Market Segmentation

  • By Type
    • Drug Discovery
      • Target Validation
      • Lead Identification
      • Lead optimization
    • Preclinical
    • Clinical
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
  • By Service
    • Project Management/Clinical Supply Management
    • Data Management
    • Regulatory/Medical Affairs
    • Medical Writing
    • Clinical Monitoring
    • Quality Management/Assurance
    • Bio-statistics
    • Investigator Payments
    • Laboratory
    • Patient and Site Recruitment
    • Technology
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Iran
      • Israel

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38688 or call: +1 9197 992 333

Daksh

Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published.